Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 7/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.30 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.30 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.30 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20998270 | 0.78 | POLB (0.42) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL20883489 | 0.78 | POLB (0.41) | POLBHSD17B10PKMDUT | |
| SCHEMBL11981174 | 0.78 | TYMP (0.40) | POLBALDH1A1LMNA | |
| SCHEMBL22475076 | 0.77 | POLB (0.46) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL14146450 | 0.77 | POLB (0.41) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL18616999 | 0.77 | POLB (0.46) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL20249093 | 0.77 | POLB (0.41) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL14546374 | 0.77 | POLB (0.41) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL12174024 | 0.77 | POLB (0.46) | POLBHSD17B10PKMCRBNALDH1A1 | |
| SCHEMBL13846328 | 0.76 | POLB (0.41) | POLBHSD17B10PKMCRBNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236945-B2 | Process for preparing disulfides and thiosulphinates and compounds prepared | Universite Joseph Fourier (Grenoble1) (FR) | 2012-08-07 | — | — | US | disclosed |
| US-20090264637-A1 | PROCESS FOR PREPARING DISULPHIDES AND THIOSULPHINATES AND COMPOUNDS PREPARED | UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264637-A1 | PROCESS FOR PREPARING DISULPHIDES AND THIOSULPHINATES AND COMPOUNDS PREPARED | TST, STS, MSR1 | POLB 1438/4885HSD17B10 1437/4885PKM 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.